glycerylphosphorylcholine has been researched along with Mitochondrial Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anglin, RE; Mazurek, MF; Noseworthy, MD; Rosebush, PI; Tarnopolsky, M | 1 |
| Modica-Napolitano, JS; Renshaw, PF | 1 |
2 other study(ies) available for glycerylphosphorylcholine and Mitochondrial Diseases
| Article | Year |
|---|---|
Psychiatric symptoms correlate with metabolic indices in the hippocampus and cingulate in patients with mitochondrial disorders.
Topics: Adult; Aged; Anxiety; Aspartic Acid; Case-Control Studies; Caudate Nucleus; Creatine; Female; Glutamic Acid; Glutamine; Glycerylphosphorylcholine; Gyrus Cinguli; Hippocampus; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mitochondrial Diseases; Psychiatric Status Rating Scales | 2012 |
Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder.
Topics: Animals; Bipolar Disorder; Choline; Depressive Disorder; Dose-Response Relationship, Drug; Ethanolamine; Ethanolamines; Glycerylphosphorylcholine; In Vitro Techniques; Male; Mitochondria; Mitochondrial Diseases; Oxygen Consumption; Phosphatidylethanolamines; Rats; Rats, Sprague-Dawley; Time Factors | 2004 |